Does routine thrombectomy reduce the occurrence of coronary no-reflow compared to PPCI alone in patients with STEMI?
There is a notable discrepancy in the reported rates of coronary no-reflow between core lab and investigator assessments following PPCI for STEMI.
This study from the TOTAL trial assessed the effect of routine thrombectomy versus PPCI alone on the occurrence of coronary no-reflow in patients with STEMI, finding rates of 10.9% by core lab and 6.6% by investigators.
Gjin Ndrepepa (Tue,) studied this question.